Journal of the American Academy of Dermatology
December 1, 2019
Elias ML, Lambert WC, Schwartz RADownload PDF
This study analyzed outcomes from the care of 8252 Merkel cell carcinoma patients at 1147 facilities in the US. It found that patients did better if cared for at higher volume / larger facilities. Such facilities tend to follow evidence-based guidelines, and are more likely to provide multi-disciplinary care
Merkel cell carcinoma (MCC) is a rare, aggressive malignancy that is at high risk for regional lymph node and distant metastases. In the United States, the aging population is driving brisk increases in its incidence. MCC is often first evident as an indurated, painless, red-blue or skin-colored nodule. Its diagnosis is often challenging because it clinically resembles benign neoplasms such as lipomas or epidermal cysts.
The authoritative source on Merkel cell carcinoma.
December 27, 2019